Identification of a novel breast-cancer-
โ
Lambert C.J. Dorssers; Jos Veldscholte
๐
Article
๐
1997
๐
John Wiley and Sons
๐
French
โ 177 KB
๐ 2 views
Development of anti-estrogen resistance limits the benefit of endocrine therapy of breast cancer. The mechanistic basis for resistance to the anti-estrogen tamoxifen may involve (epi)genetic alterations within tumor cells. We have initiated a random search for genes allowing estrogen-dependent ZR-75